Coherus Biosciences Inc. appointed Samuel Nussbaum to its board of directors.
The appointee is the former vice president of clinical health policy and chief medical officer of Anthem Inc., having served in those roles from 2000 to 2016.
The Redwood City, Calif.-based company said Nussbaum's appointment will help with Coherus' efforts to introduce its biosimilar medicines in the market.
